New Treatments

Novartis drug Signifor® recommended by FDA advisory committee for approval to treat patients with Cushing’s disease

Modified-release hydrocortisone (Plenadren) launched for adrenal insufficiency

Sandostatin® LAR Depot:A Long History of Control in Acromegaly